Wystepowanie Moraxella catarrhalis u chorych z zakazeniami drog oddechowych

• Autorzy: Jakubicz P. , Leszczynska K.
• Języki publikacji: PL

Abstrakty

EN

The study was undertaken to evaluate the incidence of Moraxella catarrhalis in patients with respiratory tract infections. Overall 514 specimens including 370 throat swabs and 114 sputums were examined. The 78 strains isolated basing on morphological and biochemical characteristcs were classified as Moraxella catarrhalis. The sensitivity of the strains to antibiotics was also estimated. The frequency of M. catarrhalis isolation from the throat swabs (15,9%) was higher than from the sputum (13,2%). Selected 25 specimens of sputum were tested simultaneously by quantitative and qualitative methods. Quantitative method was more sensitive (84% positive findings) than qualitative method (60% positive findings). Resistance to ampicillin was found in 52 (66,7%) strains of M. catarrhalis determined mainly by beta-lactamase production (over 70% strains were producers of beta-lactamase). All strains were sensitive to ofloxacin and amoxycillin/clavulanic acid combination. The frequency of M. catarrhalis isolation was higher in autum - winter period than in summer (May - September). We conclude that M. catarrhalis, beside Streptococcus pyogenes (20,2%) and Streptococcus pneumoniae (17,1%), arc the most frequently isolated bacteria in patients with respiratory tract infections.

Słowa kluczowe

PL

infekcja bakteryjna; wystepowanie; drogi oddechowe; choroby czlowieka; beta-laktamaza; Moraxella catarrhalis; leczenie; bakterie; ludzie chorzy

• Wydawca: -
• Czasopismo: Medycyna Doświadczalna i Mikrobiologia
• Rocznik: 1997
• Tom: 49
• Numer: 1-2
• Opis fizyczny: s.55-60,rys.,tab.,bibliogr.

Twórcy

autor

Jakubicz P.

• Akademia Medyczna, 15-230 Bialystok, ul.Mickiewicza 2a

autor

Leszczynska K.

Bibliografia

• 1. Boyle F.:Med. J. Amer., 1991, 154, 592.
• 2. Faden H., Harabuchi Y., Hong J.: J. Infect.Dis., 1994, 169, 1312.
• 3. Ikram R., Nixon M., Aitken J., Wells E.: J. Hosp. Infect., 1993, 25, 7.
• 4. Jakubicz P., Borowski J., Tarasiewicz F., Chyrek-Borowska S.: Pneum. Pol., 1986, 45, 415.
• 5. Kasprowicz A., Kuźniarska K., Turek J., Heczko P.: Med. Dośw. Microbiol., 1987, 39, 1.
• 6. Kibsey P., Rennie R., Rushton J.: J. Clin. Microbiol., 1994, 27, 86.
• 7. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disc susceptibility tests-fifth edition. Approved Standard M2-A5 NCCLS, Villanova, PA 1993.
• 8. Nowak-Sadzkowska J., Heczko P.: Pneum. Alerg. Pol., 1994, 62, 530.
• 9. Periyakoil V., Krasner C.: Clin. Infect. Dis., 1996, 23, 649.
• 10. Pervis V., Heald J.: J. Clin. Path., 1992, 45, 532.
• 11. Sehgal S., al-Shaimy I.: Infection, 1994, 22, 193.
• 12. Wood G.M., Johnson B.C.,Cormack J.G.: Clin. Infect. Dis., 1996, 22, 632.